Development of a Metastatic Uveal Melanoma Prognostic risk Score (MUMPS) for use in patients receiving immune checkpoint inhibitors

Deirdre Kelly, April A. N. Rose, Thiago Pimentel Muniz, David Hogg, Marcus O. Butler, Samuel D. Saibil, Ian King, Zaid Saeed Kamil, Danny Ghazarian, Kendra Ross, Marco Iafolla, Daniel V. Araujo, John Waldron, Normand Laperriere, Hatem Krema, Anna Spreafico
doi: https://doi.org/10.1101/2021.02.28.21252611

Article usage

Article usage: March 2021 to July 2025

AbstractFullPdf
Mar 20216761963
Apr 2021228332
May 202191414
Jun 20217954
Jul 2021401220
Aug 20219378
Sep 202130312
Oct 202134321
Nov 202133315
Dec 20212753
Jan 202214142
Feb 20221515
Mar 20221632
Apr 20222403
May 20221909
Jun 202224062
Jul 202216154
Aug 20221214
Sep 20223206
Oct 20222218
Nov 20221413
Dec 202215114
Jan 20231606
Feb 20231426
Mar 202311032
Apr 20231918
May 20231014
Jun 2023942
Jul 2023414
Aug 202317127
Sep 2023943
Oct 2023705
Nov 202317107
Dec 20231001
Jan 20241123
Feb 20241212
Mar 2024517
Apr 2024521
May 2024704
Jun 20241034
Jul 20241623
Aug 20241135
Sep 20242748
Oct 20241312
Nov 20241215
Dec 20242003
Jan 2025827
Feb 202512226
Mar 202515225
Apr 20252015
May 20253668
Jun 20251867
Jul 2025121516
Back to top
Posted March 02, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Development of a Metastatic Uveal Melanoma Prognostic risk Score (MUMPS) for use in patients receiving immune checkpoint inhibitors
Deirdre Kelly, April A. N. Rose, Thiago Pimentel Muniz, David Hogg, Marcus O. Butler, Samuel D. Saibil, Ian King, Zaid Saeed Kamil, Danny Ghazarian, Kendra Ross, Marco Iafolla, Daniel V. Araujo, John Waldron, Normand Laperriere, Hatem Krema, Anna Spreafico
medRxiv 2021.02.28.21252611; doi: https://doi.org/10.1101/2021.02.28.21252611
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area